Therapeuticsmd Stock Market Value
| TXMD Stock | USD 2.23 0.01 0.45% |
| Symbol | TherapeuticsMD |
TherapeuticsMD Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TherapeuticsMD. If investors know TherapeuticsMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TherapeuticsMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.433 | Return On Assets | Return On Equity |
The market value of TherapeuticsMD is measured differently than its book value, which is the value of TherapeuticsMD that is recorded on the company's balance sheet. Investors also form their own opinion of TherapeuticsMD's value that differs from its market value or its book value, called intrinsic value, which is TherapeuticsMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TherapeuticsMD's market value can be influenced by many factors that don't directly affect TherapeuticsMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TherapeuticsMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if TherapeuticsMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TherapeuticsMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
TherapeuticsMD 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TherapeuticsMD's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TherapeuticsMD.
| 12/20/2025 |
| 01/19/2026 |
If you would invest 0.00 in TherapeuticsMD on December 20, 2025 and sell it all today you would earn a total of 0.00 from holding TherapeuticsMD or generate 0.0% return on investment in TherapeuticsMD over 30 days. TherapeuticsMD is related to or competes with ProPhase Labs, Aytu BioScience, Biofrontera, Biomx, Gelteq Limited, Ekso Bionics, and Eterna Therapeutics. TherapeuticsMD, Inc. operates as a womens healthcare company in the United States More
TherapeuticsMD Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TherapeuticsMD's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TherapeuticsMD upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.37 | |||
| Information Ratio | 0.1831 | |||
| Maximum Drawdown | 43.93 | |||
| Value At Risk | (7.87) | |||
| Potential Upside | 16.36 |
TherapeuticsMD Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for TherapeuticsMD's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TherapeuticsMD's standard deviation. In reality, there are many statistical measures that can use TherapeuticsMD historical prices to predict the future TherapeuticsMD's volatility.| Risk Adjusted Performance | 0.1456 | |||
| Jensen Alpha | 1.2 | |||
| Total Risk Alpha | 0.4672 | |||
| Sortino Ratio | 0.2055 | |||
| Treynor Ratio | 0.6268 |
TherapeuticsMD Backtested Returns
TherapeuticsMD is dangerous given 3 months investment horizon. TherapeuticsMD owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18 % return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.26% are justified by taking the suggested risk. Use TherapeuticsMD Coefficient Of Variation of 507.32, semi deviation of 5.26, and Risk Adjusted Performance of 0.1456 to evaluate company specific risk that cannot be diversified away. TherapeuticsMD holds a performance score of 14 on a scale of zero to a hundred. The entity has a beta of 2.23, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TherapeuticsMD will likely underperform. Use TherapeuticsMD jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution , to analyze future returns on TherapeuticsMD.
Auto-correlation | 0.30 |
Below average predictability
TherapeuticsMD has below average predictability. Overlapping area represents the amount of predictability between TherapeuticsMD time series from 20th of December 2025 to 4th of January 2026 and 4th of January 2026 to 19th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TherapeuticsMD price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current TherapeuticsMD price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
TherapeuticsMD lagged returns against current returns
Autocorrelation, which is TherapeuticsMD stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting TherapeuticsMD's stock expected returns. We can calculate the autocorrelation of TherapeuticsMD returns to help us make a trade decision. For example, suppose you find that TherapeuticsMD has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
TherapeuticsMD regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If TherapeuticsMD stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if TherapeuticsMD stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in TherapeuticsMD stock over time.
Current vs Lagged Prices |
| Timeline |
TherapeuticsMD Lagged Returns
When evaluating TherapeuticsMD's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of TherapeuticsMD stock have on its future price. TherapeuticsMD autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, TherapeuticsMD autocorrelation shows the relationship between TherapeuticsMD stock current value and its past values and can show if there is a momentum factor associated with investing in TherapeuticsMD.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TherapeuticsMD is a strong investment it is important to analyze TherapeuticsMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact TherapeuticsMD's future performance. For an informed investment choice regarding TherapeuticsMD Stock, refer to the following important reports:Check out TherapeuticsMD Correlation, TherapeuticsMD Volatility and TherapeuticsMD Alpha and Beta module to complement your research on TherapeuticsMD. For information on how to trade TherapeuticsMD Stock refer to our How to Trade TherapeuticsMD Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
TherapeuticsMD technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.